KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Cash & Current Investments: 2017-2025

Historic Cash & Current Investments for Elanco Animal Health (ELAN) over the last 8 years, with Sep 2025 value amounting to $505.0 million.

  • Elanco Animal Health's Cash & Current Investments rose 3.06% to $505.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year increase of 24.70%. This contributed to the annual value of $468.0 million for FY2024, which is 32.95% up from last year.
  • Elanco Animal Health's Cash & Current Investments amounted to $505.0 million in Q3 2025, which was down 6.31% from $539.0 million recorded in Q2 2025.
  • Over the past 5 years, Elanco Animal Health's Cash & Current Investments peaked at $638.0 million during Q4 2021, and registered a low of $318.0 million during Q1 2023.
  • Over the past 3 years, Elanco Animal Health's median Cash & Current Investments value was $416.0 million (recorded in 2024), while the average stood at $423.3 million.
  • Per our database at Business Quant, Elanco Animal Health's Cash & Current Investments crashed by 58.63% in 2021 and then spiked by 41.16% in 2025.
  • Quarterly analysis of 5 years shows Elanco Animal Health's Cash & Current Investments stood at $638.0 million in 2021, then crashed by 45.92% to $345.0 million in 2022, then climbed by 2.03% to $352.0 million in 2023, then surged by 32.95% to $468.0 million in 2024, then increased by 3.06% to $505.0 million in 2025.
  • Its Cash & Current Investments stands at $505.0 million for Q3 2025, versus $539.0 million for Q2 2025 and $487.0 million for Q1 2025.